VF
OTLK icon

Virtu Financial’s Outlook Therapeutics OTLK Stock Holding History

Virtu Financial’s Portfolio OTLK Stock Details OTLK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-112,786
Closed -$23K – 2077
2026
Q1 		$23K Buy
+112,786
New +$48.7K ﹤0.01% 1379
2024
Q2 		– Sell
-18,213
Closed -$217K – 1740
2024
Q1 		$217K Buy
18,213
+14,806
+435% +$120K 0.02% 754
2023
Q4 		$27K Buy
+3,407
New +$28.8K ﹤0.01% 1273
2023
Q1 		– Sell
-1,872
Closed -$40K – 1942
2022
Q4 		$40K Buy
+1,872
New +$40.7K 0.01% 1120
2022
Q3 		– Sell
-1,056
Closed -$22K – 2101
2022
Q2 		$22K Buy
+1,056
New +$30.4K ﹤0.01% 1313
2021
Q3 		– Sell
-707
Closed -$35K – 1833
2021
Q2 		$35K Sell
707
-161
-19% -$7.47K ﹤0.01% 1378
2021
Q1 		$39K Sell
868
-4,679
-84% -$179K ﹤0.01% 1458
2020
Q4 		$144K Buy
5,547
+4,506
+433% +$94.2K 0.02% 957
2020
Q3 		$15K Buy
+1,041
New +$23.2K ﹤0.01% 940
2019
Q4 		$34K Buy
2,893
+122
+4% +$2.84K ﹤0.01% 1263
2019
Q3 		$83K Buy
+2,771
New +$107K 0.01% 1119
2018
Q1 		– Sell
-177
Closed -$37K – 2413
2017
Q4 		$37K Sell
177
-5
-3% -$1.04K ﹤0.01% 2125
2017
Q3 		$40K Buy
+182
New +$33.1K ﹤0.01% 2258

Other funds holding OTLK

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
GWM
Gilpin Wealth Management Denver, Colorado $145M AUM

Virtu Financial's OTLK Position: Q2 2026 in Review

Virtu Financial sold out of Outlook Therapeutics (OTLK) in Q2 2026, closing a stake of 112,786 shares — an estimated $23K sold.

Virtu Financial first reported a position in OTLK in Q3 2017 and held it in 13 quarters. The position peaked at $217K in Q1 2024. 69 funds tracked by Wall St. Rank hold OTLK as of Q2 2026.

  • Virtu Financial reported no remaining Outlook Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Virtu Financial sold 112,786 Outlook Therapeutics shares in Q2 2026, an estimated $23K.
  • Virtu Financial first reported a position in Outlook Therapeutics in Q3 2017 and held it in 13 quarters.
  • Virtu Financial's Outlook Therapeutics position peaked at $217K in Q1 2024.
  • 69 funds tracked by Wall St. Rank held Outlook Therapeutics as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.